| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 04/19/2011 | CA2560417C 1,2-diarylimidazole-4-carboxamide derivatives |
| 04/19/2011 | CA2553704C Substituted benzimidazoles and their use for inducing apoptosis |
| 04/19/2011 | CA2539853C Isoquinolinone potassium channel inhibitors |
| 04/19/2011 | CA2476012C Substituted pyridinones as modulators of p38 map kinase |
| 04/19/2011 | CA2464000C 2-phenyl benzimidazoles and imidazo-[4,5]-pyridines as cdsi/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer |
| 04/19/2011 | CA2437813C Synthesis method and intermediates of pyridin-2-yl-methylamine |
| 04/19/2011 | CA2393802C 3-aminoquinazolin-2,4-dione antibacterial agents |
| 04/14/2011 | WO2011044197A1 Spirocyclic compounds as modulators of chemokine receptor activity |
| 04/14/2011 | WO2011044001A1 Compounds and compositions as modulators of gpr119 activity |
| 04/14/2011 | WO2011043480A1 Homocysteine synthase inhibitor |
| 04/14/2011 | WO2011043479A1 Therapeutic agent for cerebral infarction |
| 04/14/2011 | WO2011042910A2 Optical resolution of substituted 2-(2- pyridinylmethylsulphinyl)-1h-benzimidazoles |
| 04/14/2011 | WO2011042798A1 Pyrazoles derivatives modulators of calcium release -activated calcium channel and methods for treatment of non- small cell lung cancer |
| 04/14/2011 | WO2011042797A1 Pyrazole derivatives as modulators of calcium release -activated calcium channel |
| 04/14/2011 | WO2011042477A1 Substituted pyrroles and imidazoles as estrogen receptor ligands |
| 04/14/2011 | WO2011042389A2 Phenylpyri(mi)dinylazoles |
| 04/14/2011 | WO2011042368A1 Fluoro-substituted 3,5-dicyano-4-(1h-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives and methods of use thereof |
| 04/14/2011 | WO2011042367A1 Fluorinated 2,6-dialkyl-3,5-dicyano-4-(1h-indazol-5-yl)-1,4-dihydropyridines and methods of use thereof |
| 04/14/2011 | WO2010142766A3 Pyrimidine derivatives as zap-70 inhibitors |
| 04/14/2011 | WO2010006713A3 Heterocyclic compounds used as pesticides |
| 04/14/2011 | US20110087029 Process for Preparing Pyridyl-Substituted Pyrazoles |
| 04/14/2011 | US20110087027 Synthetic methods for spiro-oxindole compounds |
| 04/14/2011 | US20110086889 Tetrazole compounds as orexin receptor antagonists |
| 04/14/2011 | US20110086885 Indole-2-carboxylic acid amides |
| 04/14/2011 | US20110086884 Barium salt of benzimidazole derivative |
| 04/14/2011 | US20110086879 Carboxamide compounds and their use as calpain inhibitors |
| 04/14/2011 | US20110086860 Compound |
| 04/14/2011 | US20110086854 Novel n-substituted-pyrrolidines as inhibitors of mdm2-p-53 interactions |
| 04/14/2011 | US20110086836 Substituted Phenylpiperidine Derivatives As Melanocortin-4 Receptor Modulators |
| 04/14/2011 | US20110086834 Alkynyl alcohols as kinase inhibitors |
| 04/14/2011 | US20110086822 Substituted Tetracycline Compounds |
| 04/14/2011 | US20110086759 Chemical compounds |
| 04/14/2011 | US20110085978 Novel quinolinylamide derivatives useful as modulators of dopamine and serotonin receptors |
| 04/14/2011 | US20110084256 Condensed-cyclic compound and organic light emitting diode including organic layer containing the condensed-cyclic compound |
| 04/14/2011 | CA2784277A1 Pyrazoles derivatives modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer |
| 04/14/2011 | CA2776842A1 Pyrazole derivatives as modulators of calcium release-activated calcium channel |
| 04/14/2011 | CA2776690A1 Heterocyclic compounds useful as pdk1 inhibitors |
| 04/14/2011 | CA2774573A1 Compounds and compositions as modulators of gpr119 activity |
| 04/14/2011 | CA2773676A1 Fluoro-substituted 3,5-dicyano-4-(1h-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives and methods of use thereof |
| 04/14/2011 | CA2773467A1 Fluorinated 2,6-dialkyl-3,5-dicyano-4-(1h-indazol-5-yl)-1,4-dihydropyridines and methods of use thereof |
| 04/14/2011 | CA2773205A1 Phenylpyri(mi)dinylazoles |
| 04/13/2011 | EP2308873A1 Bicyclic-substituted amines having cyclic-substituted monocyclic substituents |
| 04/13/2011 | EP2308870A2 2-oxo-1-pyrrolidine deriatives, processes for preparing them and their uses |
| 04/13/2011 | EP2308869A1 Azole compound |
| 04/13/2011 | EP2308868A1 Histone deacetylase inhibitors and uses thereof |
| 04/13/2011 | EP2308867A2 2-oxo-1-pyrrolidine deriatives, processes for preparing them and their uses |
| 04/13/2011 | EP2308866A1 Phenylpyri(mi)dinylpyrazoles and their use as fungicides |
| 04/13/2011 | EP2308861A1 Macrocyclic compounds useful as pharmaceuticals |
| 04/13/2011 | EP2308855A1 2,4-Diaminopyrimidine derivatives |
| 04/13/2011 | EP2308854A1 2,3,6-trisubstituted-4-pyrimidone derivatives |
| 04/13/2011 | EP2308848A1 Quinoline-derived amide modulators of vanilloid VR1 receptor |
| 04/13/2011 | EP2308843A1 Condensed-cyclic compound and organic light emitting diode including organic layer containing the condensed-cyclic compound |
| 04/13/2011 | EP2308840A1 GPCR agonists |
| 04/13/2011 | EP2308812A2 N-acylsulfonamide apoptosis promoters |
| 04/13/2011 | EP2308562A2 Azetidine ring compounds and drugs comprising the same |
| 04/13/2011 | EP2308492A1 Process for preparing lansoprazole |
| 04/13/2011 | EP2307401A2 Antineoplastic derivatives of 4-oxo-1,4-dihydro-quinoline, preparation thereof, and therapeutic use thereof |
| 04/13/2011 | EP2307400A2 Inhibitors of pi3 kinase |
| 04/13/2011 | EP2307387A1 Novel heterocyclyl compounds for treatment of cardiovascular disease |
| 04/13/2011 | EP2307385A1 2 -arylaminoquinazolines for treating proliferative diseases |
| 04/13/2011 | EP2307383A1 Aminotetrahydroindazoloacetic acids |
| 04/13/2011 | EP2307382A1 Aminotetrahydroindazoloacetic acids |
| 04/13/2011 | EP2307379A2 Organic compounds |
| 04/13/2011 | EP2307378A1 Nicotinamide derivatives |
| 04/13/2011 | EP2307371A2 Organic compounds |
| 04/13/2011 | EP2307368A1 Compound comprising phenyl pyridine units |
| 04/13/2011 | EP2307365A1 Synthesis and use of heterocyclic antibacterial agents |
| 04/13/2011 | EP2307024A1 Substituted carbamate derivatives as modulators of corticotropin-releasing factor receptor activity |
| 04/13/2011 | EP2307008A1 Substituted indolyl and indazolyl derivatives and uses thereof |
| 04/13/2011 | EP2306995A1 Antitumor properties of no modified protease inhibitors |
| 04/13/2011 | EP2306828A1 Prolyl hydroxylase inhibitors |
| 04/13/2011 | EP2188252B1 1-(4-(4-benzylbenzamido)-benzyl)azetidine-3-carboxylic acid derivatives and related compounds as s1p receptor modulators for the treatment of immune disorders |
| 04/13/2011 | EP2125744B1 Cycloalkylamine substituted isoquinolone and isoquinolinone derivatives |
| 04/13/2011 | EP2013198B1 Solid-state form of amg 706 and pharmaceutical compositions thereof |
| 04/13/2011 | EP1896466B1 N-linked heterocyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 04/13/2011 | EP1548005B1 Process for producing 2-substituted pyridine derivative |
| 04/13/2011 | EP1140085B1 Azabicycloalkanes as ccr5 modulators |
| 04/13/2011 | CN1926109B Substituted 1,2,3,4-tetrahydroisoquinoline derivatives |
| 04/13/2011 | CN1882547B 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 04/13/2011 | CN1726209B 3-substituted-4-pyrimidone derivatives |
| 04/13/2011 | CN1625400B 2,4-pyrimidinediamine compounds and their uses |
| 04/13/2011 | CN102015689A Inhibitors of JNK |
| 04/13/2011 | CN102015688A Muscarinic receptor agonists, compositions, methods of treatment thereof, and processes for preparation thereof |
| 04/13/2011 | CN102015687A Muscarinic receptor agonists, compositions, methods of treatment thereof, and processes for preparation thereof 177 |
| 04/13/2011 | CN102015686A Novel heterocyclic compounds and uses therof |
| 04/13/2011 | CN102015685A Substituted dihydropyrazolones as inhibitors of HIF-prolyl-4-hydroxylases |
| 04/13/2011 | CN102015684A Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists |
| 04/13/2011 | CN102015683A Substituted indole derivatives |
| 04/13/2011 | CN102015682A 3, 4 - substituted piperidine derivatives as renin inhibitors |
| 04/13/2011 | CN102015681A Crystal form of phenylamino pyrimidine derivatives |
| 04/13/2011 | CN102015680A New substituted indolin-2-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
| 04/13/2011 | CN102015678A Fused pyridines active as inhibitors of c-Met |
| 04/13/2011 | CN102015677A Pyrimidinone derivatives and methods of use thereof |
| 04/13/2011 | CN102015661A Arylpyrazinone derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 04/13/2011 | CN102015660A 2-aminoquinazoline derivative |
| 04/13/2011 | CN102015659A Substituted pyridazinylmethyl sulfonamides |
| 04/13/2011 | CN102015656A Phenylpropionic acid derivative and use thereof |
| 04/13/2011 | CN102015655A Trisubstituted pyrazoles as acetylcholine receptor modulators |
| 04/13/2011 | CN102015646A Azomethine direct dyes or reduced precursors of these dyes obtained from 2-amino-3-hydroxypyridine, and hair dyeing process using these dyes and precursors |
| 04/13/2011 | CN102015645A Piperidine and pyrrolidine compounds |